Page last updated: 2024-09-05

zeneca zd 6169 and Bladder Disorder, Neurogenic

zeneca zd 6169 has been researched along with Bladder Disorder, Neurogenic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Karim, AM; Bialecki, RA; Elhilali, MM1
Brioni, JD; Brune, ME; Coghlan, MJ; Fabiyi, AC; Gopalakrishnan, M; Lynch, JJ1

Other Studies

2 other study(ies) available for zeneca zd 6169 and Bladder Disorder, Neurogenic

ArticleYear
Effects of ZD6169 and ZD0947, 2 potassium adenosine triphosphate channel openers, on bladder function of spinalized rats.
    The Journal of urology, 2002, Volume: 168, Issue:2

    Topics: Amides; Animals; Benzophenones; Dihydropyridines; Dose-Response Relationship, Drug; Female; Muscle Hypertonia; Potassium Channels; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Urinary Bladder, Neurogenic; Urodynamics

2002
In vivo evaluation of the potency and bladder-vascular selectivity of the ATP-sensitive potassium channel openers (-)-cromakalim, ZD6169 and WAY-133537 in rats.
    BJU international, 2003, Volume: 91, Issue:3

    Topics: Amides; Animals; Benzophenones; Calcium Channels; Cromakalim; Cyclobutanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Male; Muscarinic Antagonists; Muscle Contraction; Nitriles; Rats; Rats, Sprague-Dawley; Reflex, Abnormal; Urinary Bladder; Urinary Bladder Neck Obstruction; Urinary Bladder, Neurogenic; Vasodilator Agents

2003